Cytokinetics Inc (CYTK)
54.71
-1.24
(-2.22%)
USD |
NASDAQ |
Nov 14, 16:00
54.71
0.00 (0.00%)
After-Hours: 20:00
Cytokinetics Gross Profit (Annual): -322.59M for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | -322.59M |
| December 31, 2022 | -146.22M |
| December 31, 2021 | -89.51M |
| December 31, 2020 | -41.12M |
| December 31, 2019 | -59.26M |
| December 31, 2018 | -57.63M |
| December 31, 2017 | -76.93M |
| December 31, 2016 | 46.51M |
| Date | Value |
|---|---|
| December 31, 2015 | -17.74M |
| December 31, 2014 | 2.514M |
| December 31, 2013 | -18.80M |
| December 31, 2012 | -28.08M |
| December 31, 2011 | -33.18M |
| December 31, 2010 | -35.44M |
| December 31, 2009 | 81.54M |
| December 31, 2008 | 12.42M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
-322.59M
Minimum
2023
-41.12M
Maximum
2020
-131.74M
Average
-89.51M
Median
2021
Gross Profit (Annual) Benchmarks
| Alnylam Pharmaceuticals Inc | 1.518B |
| Biomarin Pharmaceutical Inc | 1.904B |
| Catalyst Pharmaceuticals Inc | 346.24M |
| Sarepta Therapeutics Inc | 1.093B |
| Ocugen Inc | -- |